Healthcare

Healthcare spending in the U.S. exceeds $2 trillion, accounting for approximately 16% of GDP and is expected to continue to grow faster than national income over the foreseeable future. New screening, detecting and imaging technologies continue to improve early detection of diseases. New treatments, based on medication, medical devices or medical procedures are continuing to increase survival rates and quality of life metrics for patients. At the same time, healthcare spending is continuing to increase due to a combination of new and expensive treatments, an aging population, longer life spans and greater prevalence of chronic illnesses.

The need to control the rise in medical costs is pushing the markets to develop new business models and forcing providers to seek cost containment through technology, coordination of care, and outsourcing. With the healthcare consumer being asked to share a higher degree of the cost of healthcare expenditures, healthcare itself is becoming more consumer-driven, bringing with it the need for more transparency in terms of pricing and choice. Health & Wellness initiatives are getting increased focus in form of prevention to curb healthcare spending and to improve quality of life, with providers, employers and payors along with consumers looking for innovative approaches.

Bryant Park Capital has a strong historic focus in the field of healthcare, providing merger & acquisition and capital raising advisory services. Over the years, Bryant Park has been a reliable source of market knowledge for clients and is the right choice for companies who want to enter or exit a healthcare business. Our senior healthcare bankers have been investors and executives in healthcare companies, which allows them to bring a unique understanding of the value proposition, as well as the opportunities and challenges of our clients.

We have completed numerous transactions in the sector in areas such as: